Assessing Serum Ferritin Together with Some Inflammatory Biomarkers in Overweight and Obese Hospital Care Workers at Elgalaa Teaching Hospital and Its Correlation with Metabolic Syndrome

Astratt

Obesity is known to be associated with elevated levels of inflammatory markers. One of the major problems associated with morbidity and mortality. The aim of the study was to assess the posing effect of obesity on the levels of serum ferritin, total cholesterol, HDL and LDL, triglycerides, HBA1C, CRP, and Uric acid with CBC, on random well-being colleague females. Patient and methods: 100 adult female health workers were categorized into three entities according to both BMI and waist circumference, as normal, overweight, and obese. Results: increased serum ferritin as an inflammatory marker might correlate to BMI, in juniors; and might be a late sign of inflammation in obesity in older age. Conclusion was that any increase in one or all of the serum ferritin, total serum cholesterol, reduction of HDL-cholesterol, triglycerides, HbA1c, CRP, or uric acid laboratory examination, could correlate with assessment of body fat distribution therapeutics plan to prevent aggravation of metabolic syndrome.